Literature DB >> 9018874

IgG effector mechanisms.

M R Clark1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9018874

Source DB:  PubMed          Journal:  Chem Immunol        ISSN： 0079-6034


× No keyword cloud information.
  36 in total

1.  Plasma half-life extension of small recombinant antibodies by fusion to immunoglobulin-binding domains.

Authors:  Meike Hutt; Aline Färber-Schwarz; Felix Unverdorben; Fabian Richter; Roland E Kontermann
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

2.  High affinity mouse-human chimeric Fab against hepatitis B surface antigen.

Authors:  Biplab Bose; Navin Khanna; Subrat K Acharya; Subrata Sinha
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

3.  Porcine IgG: structure, genetics, and evolution.

Authors:  J E Butler; Nancy Wertz; Nicholas Deschacht; Imre Kacskovics
Journal:  Immunogenetics       Date:  2008-12-02       Impact factor: 2.846

4.  Generation and characterization of high affinity humanized fab against hepatitis B surface antigen.

Authors:  Ashutosh Tiwari; Durgashree Dutta; Navin Khanna; Subrat K Acharya; Subrata Sinha
Journal:  Mol Biotechnol       Date:  2009-03-27       Impact factor: 2.695

5.  IgG2m4, an engineered antibody isotype with reduced Fc function.

Authors:  Zhiqiang An; Gail Forrest; Renee Moore; Michael Cukan; Peter Haytko; Lingyi Huang; Salvatore Vitelli; Jing Zhang Zhao; Ping Lu; Jin Hua; Christopher R Gibson; Barrett R Harvey; Donna Montgomery; Dennis Zaller; Fubao Wang; William Strohl
Journal:  MAbs       Date:  2009 Nov-Dec       Impact factor: 5.857

6.  Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.

Authors:  M Jack Borrok; Nadia M Luheshi; Nurten Beyaz; Gareth C Davies; James W Legg; Herren Wu; William F Dall'Acqua; Ping Tsui
Journal:  MAbs       Date:  2015       Impact factor: 5.857

7.  Expanding the Scope of Antibody Rebridging with New Pyridazinedione-TCO Constructs.

Authors:  Angela N Marquard; Jonathan C T Carlson; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2020-04-28       Impact factor: 4.774

8.  Immunoglobulin-specific responses to Chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection.

Authors:  William M Geisler; Sandra G Morrison; Martha L Doemland; Shehzad M Iqbal; Jin Su; Ausra Mancevski; Edward W Hook; Richard P Morrison
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

Review 9.  Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.

Authors:  P Ronco; H Debiec
Journal:  Semin Immunopathol       Date:  2007-09-26       Impact factor: 9.623

10.  Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC.

Authors:  Akito Natsume; Rinpei Niwa; Mitsuo Satoh
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.